×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
US FDA approves X4 Pharmaceuticals' therapy for immunodeficiency disease
Reuters
X4 Pharmaceuticals said on Monday the U.S. FDA has approved its therapy to treat a rare genetic immunodeficiency disease in patients 12...
1 month ago
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q1 2024 Earnings Call Transcript
Yahoo Finance
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Q1 2024 Earnings Call Transcript May 7, 2024 X4 Pharmaceuticals, Inc. misses on earnings expectations...
3 weeks ago
FDA approves X4 Pharmaceuticals' WHIM syndrome drug
Pharmaceutical Technology
The US FDA has approved X4 Pharmaceuticals' XOLREMDI (mavorixafor) capsules for patients aged 12 and above with WHIM syndrome.
4 weeks ago
X4 enters commercial fold with FDA approval of rare disease drug Xolremdi
Fierce Pharma
With the approval, Xolremdi has become the first drug specifically FDA-approved to treat WHIM, which is a rare, combined primary...
1 month ago
X4 Pharmaceuticals: PDUFA Excitement Ahead (NASDAQ:XFOR)
Seeking Alpha
(NASDAQ:XFOR) a development-stage pharma. Its NDA for its lead molecule mavorixafor in treatment of WHIM (warts, hypogammaglobulinemia,...
1 month ago
X4 Pharmaceuticals to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
GlobeNewswire
BOSTON, May 13, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare...
2 weeks ago
48% Of This X4 Pharmaceuticals Insider's Holdings Were Sold
Simply Wall Street
X4 Pharmaceuticals. A late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel...
4 weeks ago
X4 Pharmaceuticals Gets FDA Approval for Xolremdi Capsules
MarketWatch
By Chris Wack X4 Pharmaceuticals said that the Food and Drug Administration approved Xolremdi capsules for use in patients 12 years of age...
1 month ago
X4 Pharmaceuticals: Q1 Earnings Snapshot
Houston Chronicle
BOSTON (AP) — BOSTON (AP) — X4 Pharmaceuticals, Inc. (XFOR) on Tuesday reported a...
3 weeks ago
X4 Pharmaceuticals Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Corporate Update
Yahoo Finance
X4 Pharmaceuticals Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Corporate Update · 2023 Highlights and Expected...
2 months ago